JP Morgan Chase
PETS icon

JP Morgan Chase’s PetMed Express PETS Stock Holding History

JP Morgan Chase’s Portfolio PETS Stock Details PETS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.78K Buy
+804
New +$2.33K ﹤0.01% 7036
2025
Q4 		– Sell
-5,851
Closed -$14.7K – 7694
2025
Q3 		$14.7K Sell
5,851
-67,552
-92% -$209K ﹤0.01% 6559
2025
Q2 		$244K Sell
73,403
-37,196
-34% -$132K ﹤0.01% 5144
2025
Q1 		$463K Buy
110,599
+3,645
+3% +$16.6K ﹤0.01% 4829
2024
Q4 		$516K Buy
106,954
+83,473
+355% +$391K ﹤0.01% 5022
2024
Q3 		$86.4K Sell
23,481
-64,471
-73% -$228K ﹤0.01% 5760
2024
Q2 		$356K Sell
87,952
-36,933
-30% -$158K ﹤0.01% 4856
2024
Q1 		$598K Sell
124,885
-4,674
-4% -$27.2K ﹤0.01% 4681
2023
Q4 		$979K Buy
129,559
+58,003
+81% +$476K ﹤0.01% 4344
2023
Q3 		$733K Buy
71,556
+6,288
+10% +$77.6K ﹤0.01% 4274
2023
Q2 		$900K Buy
65,268
+8,578
+15% +$129K ﹤0.01% 4137
2023
Q1 		$920K Buy
56,690
+15,382
+37% +$290K ﹤0.01% 4103
2022
Q4 		$731K Buy
41,308
+3,731
+10% +$74.1K ﹤0.01% 4264
2022
Q3 		$733K Buy
37,577
+6,871
+22% +$146K ﹤0.01% 4236
2022
Q2 		$611K Buy
30,706
+4,963
+19% +$111K ﹤0.01% 4433
2022
Q1 		$664K Sell
25,743
-18,095
-41% -$469K ﹤0.01% 4522
2021
Q4 		$1.11M Sell
43,838
-17,089
-28% -$473K ﹤0.01% 4318
2021
Q3 		$1.64M Sell
60,927
-29,696
-33% -$855K ﹤0.01% 3942
2021
Q2 		$2.89M Buy
90,623
+104
+0.1% +$3.3K ﹤0.01% 3520
2021
Q1 		$3.18M Buy
90,519
+18,230
+25% +$634K ﹤0.01% 3351
2020
Q4 		$2.32M Buy
72,289
+20,769
+40% +$640K ﹤0.01% 3375
2020
Q3 		$1.62M Buy
51,520
+413
+0.8% +$13.7K ﹤0.01% 3371
2020
Q2 		$1.82M Sell
51,107
-31,995
-39% -$1.11M ﹤0.01% 3168
2020
Q1 		$2.39M Buy
83,102
+59,022
+245% +$1.55M ﹤0.01% 2832
2019
Q4 		$566K Buy
24,080
+10,754
+81% +$241K ﹤0.01% 4170
2019
Q3 		$240K Sell
13,326
-1,063
-7% -$17.6K ﹤0.01% 4548
2019
Q2 		$228K Sell
14,389
-40,416
-74% -$795K ﹤0.01% 4613
2019
Q1 		$1.25M Sell
54,805
-35,396
-39% -$798K ﹤0.01% 3670
2018
Q4 		$2.1M Buy
90,201
+32,071
+55% +$856K ﹤0.01% 3239
2018
Q3 		$1.92M Buy
58,130
+50,756
+688% +$1.9M ﹤0.01% 3494
2018
Q2 		$326K Sell
7,374
-13,792
-65% -$534K ﹤0.01% 4357
2018
Q1 		$884K Sell
21,166
-80,553
-79% -$3.72M ﹤0.01% 3741
2017
Q4 		$4.63M Buy
101,719
+65,220
+179% +$2.57M ﹤0.01% 2746
2017
Q3 		$1.22M Buy
36,499
+24,844
+213% +$1.01M ﹤0.01% 3411
2017
Q2 		$473K Sell
11,655
-38,421
-77% -$1.19M ﹤0.01% 3755
2017
Q1 		$1.01M Sell
50,076
-42,985
-46% -$909K ﹤0.01% 3406
2016
Q4 		$2.15M Buy
93,061
+22,799
+32% +$488K ﹤0.01% 3026
2016
Q3 		$1.43M Sell
70,262
-10,904
-13% -$220K ﹤0.01% 2973
2016
Q2 		$1.52M Buy
81,166
+36,119
+80% +$664K ﹤0.01% 2951
2016
Q1 		$807K Buy
45,047
+13,670
+44% +$234K ﹤0.01% 3154
2015
Q4 		$538K Buy
+31,377
New +$527K ﹤0.01% 3362
2014
Q4 		– Sell
-20,094
Closed -$273K – 4322
2014
Q3 		$273K Sell
20,094
-481
-2% -$6.7K ﹤0.01% 3900
2014
Q2 		$278K Sell
20,575
-218,268
-91% -$2.88M ﹤0.01% 3296
2014
Q1 		$3.2M Sell
238,843
-147,800
-38% -$2.05M ﹤0.01% 2326
2013
Q4 		$6.43M Sell
386,643
-13,166
-3% -$206K ﹤0.01% 2013
2013
Q3 		$6.51M Buy
399,809
+23,486
+6% +$366K ﹤0.01% 2024
2013
Q2 		$4.74M Buy
+376,323
New +$4.91M ﹤0.01% 2173

Other funds holding PETS

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPH
Steel Partners Holdings New York $96.4M AUM
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

JP Morgan Chase's PETS Position: Q1 2026 in Review

JP Morgan Chase opened a new position in PetMed Express (PETS) in Q1 2026: 804 shares worth $1.78K. The stake represents ﹤0.01% of the portfolio and ranks #7036 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in PETS as recently as Q3 2025.

JP Morgan Chase first reported a position in PETS in Q2 2013 and has held it in 47 quarters since. The position peaked at $6.51M in Q3 2013. 49 funds tracked by Wall St. Rank hold PETS as of Q1 2026.

  • JP Morgan Chase held 804 shares of PetMed Express worth $1.78K as of Q1 2026.
  • PetMed Express was a new JP Morgan Chase position in Q1 2026.
  • PetMed Express made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7036 holding.
  • JP Morgan Chase first reported a position in PetMed Express in Q2 2013 and has held it in 47 quarters since.
  • JP Morgan Chase's PetMed Express position peaked at $6.51M in Q3 2013.
  • 49 funds tracked by Wall St. Rank held PetMed Express as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.